Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients
Pautier, Patricia, Locher, Clara, Robert, Caroline, Deroussent, Alain, Flament, Caroline, Le Cesne, Axel, Rey, Annie, Bahleda, Ratislav, Ribrag, Vincent, Soria, Jean-Charles, Vassal, Gilles, EggermontVolume:
2
Language:
english
Journal:
OncoImmunology
DOI:
10.4161/onci.23079
Date:
February, 2013
File:
PDF, 1.03 MB
english, 2013